Annals of Oncology - Temmuz 2010

Reviews
 

• Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients
  Ann Oncol (2010)21(7):1395-1403published ahead of print January 29, 2010 doi:10.1093/annonc/mdp598
• Taking care of smoker cancer patients: a review and some recommendations
  Ann Oncol (2010)21(7):1404-1409published ahead of print January 20, 2010 doi:10.1093/annonc/mdp599

ORIGINAL ARTICLES

• Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
  Ann Oncol (2010)21(7):1411-1418published ahead of print November 30, 2009 doi:10.1093/annonc/mdp552
• Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
  Ann Oncol (2010)21(7):1430-1435published ahead of print January 20, 2010 doi:10.1093/annonc/mdp585
• An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
  Ann Oncol (2010)21(7):1436-1441published ahead of print December 23, 2009 doi:10.1093/annonc/mdp565
• Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
  Ann Oncol (2010) 21(7): 1442-1447published ahead of print November 25, 2009 doi:10.1093/annonc/mdp536
• Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
  Ann Oncol (2010)21(7):1492-1499published ahead of print December 11, 2009 doi:10.1093/annonc/mdp544
• Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
  Ann Oncol (2010)21(7):1515-1522published ahead of print December 23, 2009 doi:10.1093/annonc/mdp573